Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Methylphenidate (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms ADMET
- 20 Nov 2015 Biomarkers information updated
- 01 Aug 2013 Results published in the Journal of Clinical Psychiatry.
- 19 Jul 2012 Preliminary results will be presented at the 2012 International Conference on Alzheimer's Disease.